BeiGene , Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that will change its name to BeOne Medicines Lt ...

First-line treatment with nivolumab (Opdivo) and ipilimumab (Yervoy) significantly improved survival compared with lenvatinib ...

In recent years, the consumption of highly processed foods has become increasingly prevalent in modern diets. While these foods may be convenient and appealing, their impact on our health can be ...

If left untreated, it can progress to more severe conditions like cirrhosis or liver cancer. The main cause of fatty liver is the accumulation of triglycerides in liver cells. This buildup can ...

Ultimately, this leads to patients who at one time might have been in a window for LT no longer being candidates or the indication being liver dysfunction because of a burned-out liver. Thus, we are ...

Furthermore, we extended this exemplar to other models of virus-associated cancer. Design and results Clinical grade oncolytic orthoreovirus (Reo) elicited innate immune activation within primary ...

Here, we deployed a multidimensional approach to unravel the T-cell functional landscape in primary colorectal cancers (CRC) and liver metastases ... Italian Ministry of Health and Alliance Against ...

The risk of dying from the most common form of primary liver cancer is about 30 percent higher for patients with low household income compared to those with middle or high household income ...

A skincare expert has shared the one product everyone should use to help prevent cancer, which can also make you look younger when used frequently. Dr Mamina Turegano is a board-certified ...

IT'S common knowledge that sun damage can increase your risk of developing skin cancer. But experts have warned that it takes a scarily low number of sunburns in your lifetime to make you ...

With increasing referrals to dermatology services for suspected skin cancers, early evidence suggests automated use of DERM could approximately halve the number of referrals to dermatologists within ...